198 related articles for article (PubMed ID: 9719812)
1. The biotechnology revolution and world health.
Nossal SG
Public Health Rep; 1998; 113(2):122-7. PubMed ID: 9719812
[No Abstract] [Full Text] [Related]
2. Health innovation networks to help developing countries address neglected diseases.
Morel CM; Acharya T; Broun D; Dangi A; Elias C; Ganguly NK; Gardner CA; Gupta RK; Haycock J; Heher AD; Hotez PJ; Kettler HE; Keusch GT; Krattiger AF; Kreutz FT; Lall S; Lee K; Mahoney R; Martinez-Palomo A; Mashelkar RA; Matlin SA; Mzimba M; Oehler J; Ridley RG; Senanayake P; Singer P; Yun M
Science; 2005 Jul; 309(5733):401-4. PubMed ID: 16020723
[TBL] [Abstract][Full Text] [Related]
3. Biotechnology and the developing world. Finding ways to bridge the agricultural technology gap.
Platais KW; Collinson MP
Finance Dev; 1992 Mar; ():34-6. PubMed ID: 12284926
[TBL] [Abstract][Full Text] [Related]
4. Public-private partnerships: new ways to discover, develop and deliver drugs for tropical diseases.
Hentschel CC
Southeast Asian J Trop Med Public Health; 2004; 35 Suppl 2():1-4. PubMed ID: 15906625
[No Abstract] [Full Text] [Related]
5. AIDS. Resource needs for HIV/AIDS.
Schwartländer B; Stover J; Walker N; Bollinger L; Gutierrez JP; McGreevey W; Opuni M; Forsythe S; Kumaranayake L; Watts C; Bertozzi S
Science; 2001 Jun; 292(5526):2434-6. PubMed ID: 11423619
[No Abstract] [Full Text] [Related]
6. Sustainable transfer of biotechnology to developing countries: fighting poverty by bringing scientific tools to developing-country partners.
Coloma J; Harris E
Ann N Y Acad Sci; 2008; 1136():358-68. PubMed ID: 17954678
[TBL] [Abstract][Full Text] [Related]
7. Individualized medicine and the imperative of global health.
Waldman SA; Terzic A
Clin Pharmacol Ther; 2007 Nov; 82(5):479-83. PubMed ID: 17952097
[No Abstract] [Full Text] [Related]
8. Public-private partnerships for health: their main targets, their diversity, and their future directions.
Widdus R
Bull World Health Organ; 2001; 79(8):713-20. PubMed ID: 11545327
[TBL] [Abstract][Full Text] [Related]
9. Global health public-private partnerships: IAVI, partnerships and capacity building.
Hanlin R; Chataway J; Smith J
Afr J Med Med Sci; 2007; 36 Suppl():69-75. PubMed ID: 17703568
[TBL] [Abstract][Full Text] [Related]
10. The distribution of biomedical research resources and international justice.
Resnik DB
Dev World Bioeth; 2004 May; 4(1):42-57. PubMed ID: 15086373
[TBL] [Abstract][Full Text] [Related]
11. What are today's orphaned vaccines?
Wilde H
Clin Infect Dis; 2001 Sep; 33(5):648-50. PubMed ID: 11486287
[TBL] [Abstract][Full Text] [Related]
12. Meeting the challenge of antibiotic resistance.
Cars O; Högberg LD; Murray M; Nordberg O; Sivaraman S; Lundborg CS; So AD; Tomson G
BMJ; 2008 Sep; 337():a1438. PubMed ID: 18801866
[No Abstract] [Full Text] [Related]
13. Mechanisms for collaboration between public and private veterinarians: the animal health accreditation mandate.
Le Brun Y
Rev Sci Tech; 2004 Apr; 23(1):69-77, 59-68; discussion 391-401. PubMed ID: 15200087
[TBL] [Abstract][Full Text] [Related]
14. Public health. Public-private partnerships and scientific imperialism.
Tucker TJ; Makgoba MW
Science; 2008 May; 320(5879):1016-7. PubMed ID: 18497279
[No Abstract] [Full Text] [Related]
15. Technological and social innovation: a unifying new paradigm for global health.
Gardner CA; Acharya T; Yach D
Health Aff (Millwood); 2007; 26(4):1052-61. PubMed ID: 17630448
[TBL] [Abstract][Full Text] [Related]
16. Round table. A role for public-private partnerships in controlling neglected diseases?
Ridley RG; Lob-Levyt J; Sachs J; Johns D; Evans T; Bale HE; Quick JD; Orbinski J
Bull World Health Organ; 2001; 79(8):771-7. PubMed ID: 11545335
[No Abstract] [Full Text] [Related]
17. Indian biotechnology--rapidly evolving and industry led.
Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
[No Abstract] [Full Text] [Related]
18. Cooperation forms to accelerate access to AIDS care in developing countries.
AIDS Read; 2000 Jun; 10(6):339. PubMed ID: 10881360
[No Abstract] [Full Text] [Related]
19. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
Spectar JM
Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
[No Abstract] [Full Text] [Related]
20. Oxymoron no more: the potential of nonprofit drug companies to deliver on the promise of medicines for the developing world.
Hale VG; Woo K; Lipton HL
Health Aff (Millwood); 2005; 24(4):1057-63. PubMed ID: 16012146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
